UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 31, 2024

 

OR

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from _________  to  ________

 

Commission File Number 001-14015

 

APPLIED ENERGETICS, INC.

 

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   77-0262908
(State or Other Jurisdiction of
Incorporation or Organization)
  (IRS Employer
Identification Number)
     
9070 S. Rita RoadSuite 1500
TucsonArizona
  85747
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (520) 628-7415

  

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer: Accelerated filer:
Non-accelerated filer: Smaller reporting company:
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange act.

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, par value $0.001 per share   AERG   OTCQB

 

As of May 13, 2024, there were 213,303,285 shares of the issuer’s common stock, par value $0.001 per share, outstanding.

 

 

 

 

 

 

APPLIED ENERGETICS, INC.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION
 
ITEM 1. Condensed Consolidated Unaudited Financial Statements 1
     
  Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023 1
     
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited) 2
     
  Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2024 and 2023 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (Unaudited) 4
     
  Notes to Condensed Consolidated Unaudited Financial Statements 5
     
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
     
ITEM 4. Controls and Procedures 22
     
PART II. OTHER INFORMATION
 
ITEM 1. Legal Proceedings 23
     
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
ITEM 5 Other Information 23
     
ITEM 6. Exhibits 23
     
SIGNATURES   24

 

i

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

APPLIED ENERGETICS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 

 

   March 31,   December 31, 
   2024   2023 
   (unaudited)     
Assets        
Current assets        
Cash and cash equivalents  $1,007,840   $1,319,526 
Accounts receivable   316,697    567,792 
Other assets   343,124    148,338 
Total current assets   1,667,661    2,035,656 
           
Long-term assets          
Property and equipment - net   382,124    434,563 
Right of use asset - operating   1,007,612    1,054,736 
Security deposit   17,004    17,004 
Total long-term assets   1,406,741    1,506,303 
Total assets  $3,074,402   $3,541,959 
           
Liabilities and Stockholders’ (Deficit) Equity           
Current liabilities          
Accounts payable  $249,610   $312,958 
Subscription payable   1,221,600    - 
Notes payable   189,302    - 
Due to related parties   50,000    50,000 
Operating lease liability - current   179,023    166,927 
Deferred revenue   139,326    308,908 
Accrued expenses   77,117    40,510 
Accrued dividends   48,079    48,079 
Total current liabilities   2,154,058    927,382 
           
Long-term liabilities          
Operating lease liability - non-current   946,866    994,491 
Total long-term liabilities   946,866    994,491 
Total liabilities   3,100,924    1,921,873 
           
Stockholders’ (Deficit) Equity          
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at March 31, 2024 and December 31, 2023 (Liquidation preference $340,050 and $340,050, respectively)   14    14 
Common stock, $.001 par value, 500,000,000 shares authorized; 211,370,639 and 211,236,688 shares issued and outstanding at March 31, 2024 and at December 31, 2023, respectively   211,371    211,237 
Additional paid-in capital   113,187,766    112,223,129 
Accumulated deficit   (113,425,673)   (110,814,294)
Total stockholders’ (deficit) equity    (26,522)   1,620,086 
           
Total Liabilities and Stockholders’ (Deficit) Equity   $3,074,402   $3,541,959 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

1

 

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   FOR THE
THREE MONTHS ENDED
MARCH 31,
 
   2024   2023 
         
Revenue  $134,235   $486,678 
Cost of revenue   274,432    141,272 
           
Gross profit   (140,197)   345,406 
           
Operating expenses          
General and administrative   2,316,899    2,115,267 
Selling and marketing   75,559    108,890 
Research and development   80,780    59,980 
Total operating expenses   2,473,239    2,284,137 
           
Operating loss   (2,613,436)   (1,938,731)
           
Other income/(expense)          
Other income   2,057    711 
Total other income/(expense)   2,057    711 
           
Loss before provision for income taxes   (2,611,379)   (1,938,020)
           
Provision for income taxes   
-
    
-
 
           
Net loss   (2,611,379)   (1,938,020)
           
Preferred stock dividends   (8,501)   (8,501)
           
Net loss attributable to common stockholders  $(2,619,880)  $(1,946,521)
           
Net loss attributable to common stockholders per common share - basic and diluted
  $(0.01)  $(0.01)
           
Weighted average number of common shares outstanding
   211,323,085    210,976,434 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

2

 

 

APPLIED ENERGETICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(Unaudited)

 

   Preferred Stock   Common Stock   Additional
Paid-In
   Accumulated   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance at December 31, 2023   13,602   $14    211,236,688   $211,237   $112,223,129   $(110,814,294)  $1,620,086 
Stock-based compensation   -    
-
    -    
-
    955,730    
-
    955,730 
Common stock issued on exercise of options   -    
-
    60,000    60    12,540    
-
    12,600 
Common stock issued on exercise of warrants   -    
-
    66,000    66    3,894    
-
    3,960 
Common stock issued for settlement of restricted stock units   -    
-
    11,666    12    (12)   
 
    
-
 
Common stock withheld to cover income tax withholding obligations   -    
-
    (3,715)   (4)   (7,515)   
-
    (7,519)
Net loss for the period ended March 31, 2024   -    
-
    -    
-
    
-
    (2,611,379)   (2,611,379)
Balance at March 31, 2024   13,602   $14    211,370,639   $211,371   $113,187,766   $(113,425,673)  $(26,522)

 

   Preferred Stock   Common Stock   Additional
Paid-In
   Accumulated   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance at December 31, 2022   13,602   $14    210,848,671   $210,849   $108,830,982   $(103,463,859)  $5,577,986 
Stock-based compensation   -    
-
    -    
-
    758,187    
-
    758,187 
RSU restricted stock   -    
-
    9,584    10    21,075    
-
    21,085 
Common stock issued on exercise of options   -    
-
    175,000    175    16,575    
-
    16,750 
Net loss for the period ended March 31, 2023   -    
-
    -    
-
    
-
    (1,938,020)   (1,938,020)
Balance at March 31, 2023   13,602   $14    211,033,255   $211,034   $109,626,819   $(105,401,879)  $4,435,988 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

3

 

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   FOR THE
THREE MONTHS ENDED
MARCH 31,
 
   2024   2023 
Cash Flows From Operating Activities        
Net loss  $(2,611,379)  $(1,938,020)
Adjustments to reconcile net loss to net cash used in operating activities:          
Noncash stock based compensation expense   955,730    779,272 
Amortization of ROU assets   47,124    29,012 
Depreciation and amortization   52,439    24,926 
Amortization of prepaid assets   51,855    55,390 
Changes in assets and liabilities:          
Accounts receivable   251,095    28,697 
Prepaid and deposits   (57,339)   (216,879)
ROU liabilities   (35,529)   (22,632)
Accounts payable   (63,348)   93,632 
Deferred revenue   (169,582)   
-
 
Accrued expenses and compensation   36,607    14,027 
Net cash used in operating activities   (1,542,327)   (1,152,575)
           
Cash Flows From Investing Activities          
Purchase of equipment   
-
    (32,096)
Net cash used in investing activities   
-
    (32,096)
           
Cash Flows From Financing Activities          
Repayment on note payable   
-
    (300,000)

Proceeds from note payable

   
-
    155,541 

Proceeds from stock subscription payable

   

1,221,600

    
-
 

Proceeds from the exercise of stock option and warrants

   

16,560

    

16,750

 
Tax withholdings related to net share settlement of RSU’s   (7,519)   
-
 
Net cash provided (used in) by financing activities   1,230,641    (127,709)
           
Net change in cash and cash equivalents   (311,686)   (1,312,380)
           
Cash and cash equivalents, beginning of year   1,319,526    5,640,308 
Cash and cash equivalents, at end of period  $1,007,840   $4,327,928 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $
-
   $
-
 
Cash paid for taxes  $
-
   $
-
 
           
Non-cash investing and financing activities          
Insurance financing for prepaid insurance  $189,302   $155,541 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

4

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

  

NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The unaudited condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2023, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

For the three months ended March 31, 2024, the company incurred a net loss of $2,611,379, had negative cash flows from operations of $1,542,327 and may incur additional future losses due to limited contract activity. At March 31, 2024, the company had total current assets of $1,667,661 and total current liabilities of $2,154,058, resulting in working capital deficit of $486,397. At March 31, 2024, the company had cash of $1,007,840.

 

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from government contracts, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

5

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

Trade conditions, such as exacerbated supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine, war in the Middle East, and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital, which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. The company may be unsuccessful in its effort to secure additional equity financing. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include revenue recognition, carrying amounts of long-lived assets, valuation assumptions for share-based payments, evaluation of debt modification accounting, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities.

 

Net Loss Attributable to Common Stockholders

 

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of shares underlying warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 31,347,519 and 28,757,351 for the three months ended March 31, 2024 and 2023, respectively.

 

6

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

Significant Concentrations and Risks

 

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of March 31, 2024, $505,111 was uninsured.

 

NOTE 2 – NEW ACCOUNTING STANDARDS

 

The company has reviewed all issued accounting pronouncements. The company does not expect the adoption of any pronouncements to have an impact on its results of operations or financial position.

 

NOTE 3 – NOTES PAYABLE

 

Premium Financing

 

On March 12, 2024, the company entered into an agreement with Oakwood D&O Insurance to provide financing in the amount of $189,302 for the insurance premium associated with two D&O policies. Both policies commenced March 12, 2024, and provided coverage for the next 15 months, expiring June 11, 2025. The loan bears interest at a fixed rate of 9.50% per annum and required the company to prepay $41,057 and appears on the balance sheet as a current asset. On April 12, 2024, the company commenced monthly principal and interest payments of $15,775 which was the first payment of twelve remaining months due of $189,302, the last payment of which is scheduled to be made on March 12, 2025. As of March 31, 2024, the outstanding balance on the note was $189,302 and was recorded as notes payable, a currently liability, in the company’s unaudited condensed consolidated balance sheet.

 

Notes Payable Reconciliation

 

The following reconciles notes payable as of March 31, 2024, and December 31, 2023:

 

   March 31,
2024
   December 31,
2023
 
Beginning balance  $-   $400,000 
Notes payable   189,302    155,541 
Payments on notes payable   -    (555,541)
Total   189,302    - 
Less-Notes payable – current   189,302    - 
Notes payable – non-current  $-   $- 

 

7

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

Future principal payments for the company’s Notes as of March 31, 2024, are as follows:

 

2024, nine months ended  $141,977 
2025   47,325 
Thereafter   
-
 
Total  $189,302 

 

The company’s note payable balance of $189,302 is due within the next twelve months, in accordance with the terms of note payable.

 

NOTE 4 – DUE TO RELATED PARTIES

 

It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

Authorized Capital Stock

 

During the three months ended March 31, 2023, the company issued 100,000 shares of common stock upon the exercise of 100,000 options at an exercise price of $0.07 a share. As a result, the company received $7,000 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2023, the company issued 75,000 shares of common stock upon the exercise of 75,000 options at an exercise price of $0.13 a share. As a result, the company received $9,750 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2023, the company issued the remaining 9,584 shares of common stock pursuant to a restricted stock agreement dated May 2021.

 

During the three months ended March 31, 2024, the company issued 30,000 shares of common stock upon the exercise of 30,000 options at an exercise price of $0.07 a share. As a result, the company received $2,100 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2024, the company issued 30,000 shares of common stock upon the exercise of 30,000 options at an exercise price of $0.35 a share. As a result, the company received $10,500 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2024, the company issued 66,000 shares of common stock upon exercise of warrants at an exercise price of $ 0.06 per share. The company received $3,960 in proceeds from the exercise of such options.

 

During the three months ended March 31, 2024, restricted stock units covering 11,666 shares of the company’s common stock vested. The company issued 11,666 and withheld 3,715 shares of common stock from the holder pursuant to their restricted stock unit agreements to cover its tax withholding obligation of $7,519.  

 

Commencing January 29, 2024, the company is conducting an offering of up to one million shares of its common stock, par value, $0.001 per share. To date, the company has received subscriptions in the amount of $1,221,600 but has not yet conducted a closing of the offering.

 

8

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

Preferred Stock

 

As of March 31, 2024, and December 31, 2023, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of March 31, 2024, including previously accrued dividends of $48,079 included in our balance sheet total approximately $371,127. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year.

 

Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing.

 

Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.

 

If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.

 

9

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

If the Corporation pays all or a portion of the Purchase Price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the Corporation may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the Corporation has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the Corporation and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the Corporation.

 

Share-Based Payments

 

Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan.

 

We have, from time to time, also granted non-plan options and restricted stock units to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $955,730 and $779,272 for the three months ended March 31, 2024, and 2023, respectively, which was charged to general and administrative expense.

 

The $955,730 stock-based compensation for the three months ended March 31, 2024, was comprised of $493,740 option expense, $461,990 expense from the vesting of the restricted stock.

 

The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance.

 

As of March 31, 2024, the company has $8,454,252 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years.

 

10

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

The following table summarizes the activity of our stock options for the three months ended March 31, 2024:

 

    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Contractual
Term
Outstanding
    Intrinsic
Value
 
Outstanding at December 31, 2023     26,195,434     $ 0.64       9.37     $ 226,821,848  
Granted     -       -       -       -  
Exercised     (60,000 )     (0.21 )     4.84       (290,219 )
Forfeited or expired     -       -       -       -  
Outstanding at March 31, 2024     26,135,434       0.64       5.76       227,112,067  
Outstanding and exercisable at March 31, 2024     21,379,320       0.28       5.03       107,630,786  

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table:

  

   Three Months
Ended
March 31,
   2023
Assumptions:   
Risk-free interest rate  1.261.30%
Expected dividend yield  0%
Expected volatility  112.6111.62%
Expected life (in years)  6

 

The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the three months ended March 31, 2024, was as follows:

 

   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
Nonvested at December 31, 2023   3,480,454    2.15 
Granted – restricted stock units and awards   -    - 
Granted – performance-based stock units   -    - 
Canceled   -    - 
Vested   (11,666)    6.75 
Nonvested at March 31, 2024   3,468,788   $2.15 

 

11

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

As of March 31, 2024, and December 31, 2023, there was $4,719,593 and $5,181,584, respectively in unrecognized stock- based compensation related to unvested restricted stock agreements, net of estimated forfeitures.

 

As of March 31, 2024 and December 31, 2023, the company recorded $0 and $0, respectively, in unrecognized stock- based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $0 and $0 was amortized for the three months ended March 31, 2024 and 2023, respectively. Warrant stock activity for the three months ended March 31, 2024, was as follows:

 

  

Warrant Activity

 
       Weighted
Average
Exercise
   Weighted
Average
remaining
Contractual
Term
 
   Shares   Price   (years) 
Outstanding at December 31, 2023   1,750,000   $0.0600    5.53 
Granted   -    -    - 
Exercised   (66,000)   0.0600    5.28 
Forfeited   -    -    - 
Outstanding and exercisable at March 31, 2024   1,684,000   $0.0600    5.28 

 

    Warrants Outstanding     Warrants Exercisable  
          Weighted
Avg.
Remaining
      Weighted             Weighted  
     Shares     Contractual
Life in
    Avg.
Exercise
    Shares     Avg.
Exercise
 
Range of Exercise Prices   Outstanding     Years     Price     Exercisable     Price  
$0.05 – $0.07     1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  
      1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  

 

12

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

NOTE 6 – REVENUE RECOGNITION

 

The company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the company over the contract term at a fixed contract price.

 

During the three months ended March 31, 2024, the Company modified its contract with a customer for changes in the contract specifications and requirements. The modification was for services that are not distinct from the existing contract due to the significant integration of services performed. The modification was accounted for as if it was part of the existing contract and a cumulative catch-up adjustment was recorded for the three months ended March 31, 2024.

 

Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in the contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and, therefore, are accounted for as part of the existing contract.

 

The following table summarizes the company’s accounts receivable, net,

 

    March 31,
2024
    December 31,
2023
 
Accounts receivable   $ 316,697     $ 153,029  
Unbilled receivable     -       414,763  
Total   $ 316,697     $ 567,792  

 

Concentrations

 

During the three months ended March 31, 2024, the company earned revenue from three contracts with three separate customers. The three customers accounted for a total of $134,235 in revenue or 100% of revenue recognized during the period. As of March 31, 2024, the company has $316,697 or 100% of accounts receivable recorded as current assets on the balance sheet related to these customers. During the three months ended March 31, 2023, the company earned revenue from one contract with one customer. The customer accounted for $486,678 or 100% of revenue recognized during the period. As of March 31, 2023, the company had $324,452 of accounts receivable recorded as current assets on the balance sheet related to this customer.

 

13

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

NOTE 7– COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one and escalated to $ 9.2009 per rentable square foot in year two. It is to further escalate to $11.4806 per rentable square foot in year three, $13.1740 per rentable square foot in year four and $14.9306 per rentable square foot in year five, in addition to certain operating expenses and taxes.

 

On June 7, 2023, the company entered into an amendment to extend the term of the original lease from April 26, 2026 to July31, 2028. Included in the lease amendment is extension space commencing on August 1, 2023. As of August 1, 2023 the Company has secured additional square footage in the amount of 9,805 rentable square feet (8,375 usable square feet). The initial base rent for expansion space was $9.10 per rentable square foot for year one, and escalated to $10.20 in year two, $11.30 in year three, $12.40 in year four and $13.50 in year five, plus certain operating expenses and taxes.

 

The company incurred lease expense for its operating leases of $72,272 which was included in general and administrative expenses in the statements of operation for the period ended March 31, 2024. During the three months ended March 31, 2024, the company made cash lease payments in the amount of $60,677.

 

At March 31, 2024, we had approximately $130,206 in future minimum lease payments due for the nine months ended. The below table presents the future minimum lease payments due reconciled to lease liabilities.

 

    Operating
Lease
 
For the three months ended March 31, 2024      
2024, nine months ended   $ 130,206  
2025     296,284  
2026     324,429  
2027     343,544  
2028     205,111  
Thereafter     -  
Total undiscounted lease payments     1,370,987  
Present value discount, less interest     245,099  
Lease Liability   $ 1,125,889  

 

14

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

(Unaudited)

 

Guarantees

 

The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of March 31, 2024 and 2023.

 

Litigation

 

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr.Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received 1,242,710 shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties have completed discovery, and the court has approved a summary judgment briefing schedule proposed by the parties. No trial date has been set.

 

On July 26, 2023, the company filed a complaint in the Superior Court of the State of Delaware against Gusrae Kaplan Nusbaum PLLC and Ryan Whalen, for malicious prosecution of a federal securities fraud lawsuit which was filed by these defendants against the company and certain of its directors, attorneys and their law firms and an outside consultant, in July 2019 in the United States District Court for the Southern District of New York. The complaint filed by the company alleges that the claims by these defendants against it were frivolous and prosecuted for the improper purpose of hindering the company’s prosecution of a then pending case against George Farley, the company’s former CEO, which was later settled. The complaint further alleges that the defendants prosecuted their claim with malice causing the company damages valued in excess of $40 million. On September 11, 2023, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On October 25, 2023, the company filed an opposition to the motion. The court heard oral argument on the motion on January 19, 2024, and took the motion under submission. On April 16, 2024, the court granted the motion on the grounds of lack of personal jurisdiction over the defendants. The company filed a Notice of Appeal with the Supreme Court of the State of Delaware on May 2, 2024.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

The company may, from time to time, be involved in legal proceedings arising from the normal course of business.

 

Related Party

 

In January 2023, the company made a $25,000 tax-deductible donation to Silicon Valley Defense Group (SVDG), a 501(c)(3) organization of which Christopher Donaghey, our Chief Financial and Operating Officer, is a founder and member of the Board of Directors. As its objective, SVDG “seeks to align and connect the people, capital, and ideas that will ensure allied democracies retain a durable techno-security advantage.”

 

NOTE 8 – SUBSEQUENT EVENTS 

 

The company’s management has evaluated subsequent events occurring after March 31, 2024, the date of our most recent balance sheet, through the date our financial statements were issued.

 

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.07 per share. The company received $700 in cash proceeds, minus required withholding, from the exercise of such options.

 

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.35 per share. The company received $3,500 in cash proceeds, minus required withholding, from the exercise of such options.

 

Subsequent to the year period ended March 31, 2024, the company issued 16,500 shares of common stock upon exercise of warrants at an exercise price of $0.06 per share. The company received $990 in proceeds from the exercise of such options.

 

On May 10, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600. All of the purchasers are accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933.

 

15

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Our discussion and analysis of the financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the related disclosures included elsewhere herein and in the Management’s Discussion and Analysis of Financial Condition and Results of Operations included as part of our Annual Report on Form 10-K for the year ended December 31, 2023.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the securities laws. Forward-looking statements include all statements that do not relate solely to the historical or current facts and can be identified by the use of forward-looking words such as “may,” “believe,” “will,” “would,” “could,” “should,” “expect,” “project,” “anticipate,” “estimates,” “possible,” “plan,” “strategy,” “target,” “prospect,” or “continue,” and other similar terms and phrases. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial condition and may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are described in Item 1A (Risk Factors) of our Annual Report on Form 10-K, for the year ended December 31, 2023. Although we believe that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to have been correct. We do not assume any obligation to update these forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking statements.

 

Applied Energetics, Inc., (sometimes referred to as the “company”) is a corporation organized and existing under the laws of the State of Delaware. Our executive office is located at 9070 S. Rita Road, Suite 1500, Tucson, Arizona 85747, (520) 628-7415. www. appliedenergetics.com

 

Applied Energetics, Inc., specializes in the development and manufacture of advanced high-performance lasers and optical systems and integrated guided energy systems for prospective defense, national security, industrial, biomedical, and scientific customers worldwide.

 

Technology, Capabilities, and Patents

 

Applied Energetics, Inc. is recognized as a global leader in developing the next generation optical sources exhibiting ever-increasing output energy, peak power and frequency agility while also providing decreased size, weight, and cost of these systems for customers. Applied Energetics utilizes patented, dual-use technologies to advance critical industries. Leveraging our proprietary fiber-based architecture and wavelength- and pulse-agility capability, our Ultrashort Pulse (USP) technology can enable users to achieve specific effects across different use cases with an unmatched blend of size, weight, and power attributes. While initially designed to meet the emerging needs and priorities for the national security community, our directed energy technology also has commercial applications in both the biomedical and advanced manufacturing industries.

 

The Applied Energetics scientific team is continuously innovating and expanding our patent portfolio to cover these technological breakthroughs and further enhance our suite of solutions for threat disruption for the Department of Defense, the intelligence community, and for commercial, biomedical and space applications with optical sources operating from the deep ultraviolet to the far infrared portions of the electromagnetic spectrum.

 

Applied Energetics has developed, successfully demonstrated and holds all crucial intellectual property rights to a dynamic directed energy technology called Laser Guided Energy (LGE®) and Laser Induced Plasma Channel (LIPC®). LGE and LIPC are technologies that can be used in a new generation of high-tech directed energy systems. Applied Energetics’ LGE and LIPC technologies are wholly owned by Applied Energetics and protected by one or more of Applied Energetics’ 25 issued patents and 11 Government Sensitive Patent Applications (GSPA). These GSPA’s are held under secrecy orders of the US government, providing the company with extended protection rights. The company also has nine pending patent applications. We continue to file patent applications as we deem appropriate to protect our intellectual property and enhance our competitive advantage.

 

16

 

 

Applied Energetics’ directed energy technologies are vastly different from conventional directed energy systems, i.e. Applied Energetics’ proprietary fiber-based architecture is a key differentiator for our most recent technology demonstrators. Compared with traditional continuous wave laser technologies with their larger footprints, AE’s architecture enables orders of magnitude size-weight-power reductions on all deliverables, creating powerful, dual-use and agile systems that can fit a host of platforms while delivering very high-intensity, ultrashort pulses of light to the required target. This unique directed energy solution allows extremely high peak power and energy, with target and effects tunability, and is effective against a wide variety of potential targets.

 

Applied Energetics’ unique optical fiber-based laser architectures also enable unmatched wavelength agility as well as pulse duration agility. Using innovative and highly specialized frequency shifting techniques, wavelengths can be custom tuned from the deep ultraviolet to the far infrared. In addition, temporal outputs can be adjusted from continuous wave to sub-picoseconds. The technology enables the customer to adjust the lasers’ operating parameters, ultimately creating more flexibility to change wavelength and pulse width. This feature allows for optimization of laser performance for defense or commercial applications.

 

Our proprietary USP laser technology provides a significantly more compact solution than current continuous wave laser platforms while still delivering high peak power. Continuous wave laser systems are typically used to heat a target and, during continuous illumination, this heat transfer leads to melting or charring of the material. Using continuous wave output powers that now exceed 100 kilowatts (1kW = 1000 watts), it can take anywhere from seconds to minutes to impact a target. By contrast, Applied Energetics has delivered USP lasers to national security users that exceed five terawatts (1 TW = 1 trillion watts) in peak power, with the difference being that this peak power from a USP laser is delivered in a pulse that is less than a trillionth of a second. During this short pulse duration, and having such a high peak intensity, near-instantaneous ablation of the surface of the threat takes place. The net results of our innovative USP approaches are highly effective lasers with mountable footprints that require only a fraction of the size and weight of other-directed energy technologies.

 

As Applied Energetics looks toward the future, our corporate strategic roadmap builds upon the significant value of the company’s USP laser capabilities and key intellectual property, including LGE and LIPC, to offer our prospective partners, co-developers and system integrators a variety of next-generation ultrashort pulse and frequency-agile optical sources, from the ultraviolet to the far infrared portion of the electromagnetic spectrum, to address numerous challenges within the national security, biomedical, and advanced manufacturing market sectors.

 

Recent Developments

  

Effective March 12, 2024, the grant previously awarded to Applied Energetics, Inc. from a U.S. Department of Defense customer has been transitioned into a contract. The original grant had a two-year period of performance. The new contract supersedes the May 2022 grant and carries a ceiling value of $1,217,535 under a base period of performance through November 11, 2024 and a 12-month unfunded option period that ends November 11, 2025. The company intends to provide additional information in a Current Report on Form 8-K upon approval from the government agency.

 

17

 

 

On March 5, 2024, Applied Energetics entered into an Employment Agreement with James Harrison, PhD, pursuant to which Dr. Harrison is to serve as Director of New Product Innovation, commencing on April 3, 2024. In this new role, Dr. Harrison’s responsibilities are to include setting a vision and strategy that supports and accelerates the entire development lifecycle of optical and laser products, from conceptualization to commercialization. His work is to involve collaboration with leaders across business development, operations, and scientific to drive the company’s strategic goal of providing cutting-edge laser and optical products to national security and commercial customers. For his services, the company has agreed to pay Dr. Harrison a cash salary of $200,000 per year.

 

Dr. Harrison is an experienced professional in the area of laser sources including design, manufacturing, program management and business development, with an emphasis on semiconductor and solid-state lasers. With more than 30 years of experience in opto-electronic sources, Dr. Harrison has demonstrated experience designing, building and scaling products that drive business growth and deliver customers innovative new technologies. He has held global leadership positions in engineering and research and development with tier-1 suppliers of photonics devices, where his responsibilities included providing substantial support for volume manufacturing of semiconductor lasers and packaged sources.

 

Effective February 11, 2024, Applied Energetics entered into a Memorandum of Understanding (MOU) with BluGlass Limited, a global supplier of gallium nitride (GaN) lasers to the national security, quantum and manufacturing industries, to collaborate and explore joint business opportunities that advance Applied Energetics’ laser and optical systems innovations and BluGlass’s expertise in GaN-based laser diode technologies.

 

Any resultant new laser capabilities and optical systems will be based on existing and emerging technologies currently under development within the companies. Under the MoU, the companies intend to collaborate to develop innovative solutions in technology areas critical to emerging national security and commercial markets, including new laser wavelengths and higher performance, yielding more efficient and cost-effective products. The MOU sets out the framework for collaboration, however, it is not a definitive agreement with commercial terms and timelines.

 

Effective August 23, 2023, Applied Energetics executed a contract with the Department of the Navy, Office of Naval Research with an aggregate contract price of $1.99 million payable over two years as the company performs its obligations under the contract. The objective of the contract is to develop a high-peak and high-average power USP optical system. The system is expected to demonstrate effects compatible with multiple Navy platforms and missions with an attractive size, weight, and power-cooling footprint. The company’s continuing development efforts in collaboration with ONR signify the importance of sustained development and maturation of USP-based directed energy systems to support the Navy’s technological priorities.

 

Effective May 15, 2023, Applied Energetics executed a Phase II Small Business Technology Transfer (STTR) contract with the U.S. Army at an aggregate contract price of $1.148 million payable over two years as the company performs its obligations thereunder, with the first year currently funded. The objective of this Phase II award is to further the development and testing of an IR laser system utilizing technologies that were investigated under the US Army Phase I STTR contract which the company was awarded in May 2022. This Phase II contract award follows a successful Phase I which established a computational concept with physical modeling and simulation to establish the feasibility of an IR laser system. Phase I was performed in collaboration with the James C. Wyant College of Optical Sciences at the University of Arizona. The company has continued its work under the contract, and provided all required reports, since its execution.

 

In May 2022, the Department of the Navy, Office of Naval Research (ONR) awarded Applied Energetics a $3.89 million, two-year grant, to develop an optical system capable of defeating customer-specified threats for integration onto U.S. Marine Corps(USMC) platforms. We were awarded this grant to accelerate the development and testing of Infrared (IR) optical technology with an ultrashort pulse laser (USPL) system. The overall objective is to advance and ruggedize optical technologies that can be fielded on a variety of USMC platforms and are able to operate in harsh conditions. Research under this grant has been completed and all progress reported to the program manager.

 

Effective June 7, 2023, the company entered into the First Amendment to Lease Agreement, which amended its existing Lease Agreement over its headquarters at the University of Arizona Tech Park. The amendment has expanded the Lease to add new 8,374usable square-foot suite of offices, conference rooms and cubicle areas directly across an atrium from the company’s current headquarters so that the company will occupy the entire first floor of the building. This has enabled the company to separate its public-facing facilities from its restricted access space easily. The amendment also extended the Lease over the company’s existing headquarters through July 31, 2028, and grants the company an option over 5,520 usable square feet of manufacturing space. The company moved its administrative offices into the new space in August 2023.

 

18

 

 

Ongoing Business Development Activities

 

Over the past few years, we have submitted multiple proposals to, and attended briefings with, various defense and other government agencies who have expressed an interest in our technology and applications. We believe that our efforts in this area of development have begun to produce results. In addition to the contracts which we have been awarded, our team has been invited to, and completed, multiple briefings focused on our capabilities and submissions. We intend to continue developing and submitting proposals and to be available to attend on-site briefings. We have also engaged in discussions with private entities and academic institutions with the objective of possibly collaborating on one or more projects. Some of these could result in further customer agreements or other opportunities to grow our business.

 

Applied Energetics has recently been involved with the Tulsa Innovation Labs (TIL) and Oklahoma State University (OSU) in defining opportunities to participate in the US Department of Commerce, Economic Development Administration (EDA) Tech Hubs program request for proposals. Tech Hubs was authorized by the bipartisan CHIPS and Science Act, a key part of President Biden’s Investing in America agenda, which he signed into law in August 2022. In August of 2023, Applied Energetics was a founding consortium member of the Tech Hub proposal submitted under the title of Tulsa Hub for Equitable and Trustworthy Autonomy (THETA). On October 23, 2023, the US EDA named the THETA Tech Hub as part of the historic $500 million investment in economic competitiveness and national security. This designation makes the THETA consortium eligible for $70 million or more in federal funding to accelerate the advanced development of autonomous technologies. The submitted papers specify that THETA will emphasize the development of UAS and counter-UAS (CUAS), artificial intelligence (AI), and cybersecurity technologies. As such, Applied Energetics anticipates working closely with the Unmanned Systems Research Institute (USRI) and the Oklahoma Aerospace Institute for Research and Education (OAIRE), both at Oklahoma State University, to partner on the UAS and counter-UAS technology research supporting the THETA TechHub. The completed Phase 2 proposal was submitted to the EDA on February 29, 2024 requesting funding for implementation projects to help propel the region into a self-sustaining, globally competitive TechHub.

 

For fiscal year 2024, which started on October 1, 2023, the National Defense Authorization Act (NDAA) was delayed and finally approved on December 22, 2023 (HR 2670), but the Defense Appropriations bill was not approved at that time. The NDAA sets defense spending policies, and the appropriations bills fund government spending. This impacts all proposals under review by the Department of Defense. On September 30, 2023, President Biden signed a Continuing Resolution (CR), HR 5860, which extended the government operations through November 17, 2023, and he then signed three further CRs, including HR 6363 on November 11, 2023extending through January 19, 2024, HR 2872 extending through March 1, 2024, and HR 7463, extending through March 8, 2024, as to four of the 12 annual budget bills, and through March 22, 2024 for the remaining eight. On March 23, 2024, the Defense Appropriations Bill was passed and signed by President Biden which will ensure the US government is funded through September 30, 2024 and that new government contracts can be funded during the 2024 fiscal year.

 

Strategic Plan and Analysis

 

The core of our strategy has been to continue growing our management and science teams with highly qualified individuals. This has driven our recruitment efforts in the areas of R&D, science, modeling and simulation, marketing and finance. We are also contemplating adding members to our Board of Directors and our Board of Advisors. Our board and leadership team have worked to align key innovations with our roadmap to encourage and enable internal filing for a broad, strategic, and robust intellectual property portfolio and continue surveying the literature for acquisitions of parallel intellectual property to that end. We also intend to pursue strategic corporate acquisitions in related fields and technology. The company’s management continues to explore any favorable equity financing opportunities.

 

Our goal with the Applied Energetics Strategic Plan is to increase the energy, peak power and frequency agility of USP optical sources while decreasing the size, weight, and cost of these systems. We are in the process of developing this breadth of very high peak power USP lasers and additional optical sources that have a very broad range of applicability for threat disruption for the Department of Defense, commercial, and biomedical applications, such as biophotonic illumination and imaging. Although the historical market for Applied Energetics’ LGE and USP technology is the U.S. Government, the USP technologies are expected to provide numerous platforms for commercial additive and subtractive manufacturing and biomedical and imaging markets, creating a substantially larger market for our products to address. Since 2020, the Applied Energetics team has been able to develop partnership and teaming arrangements with the three leading laser and optics institutes in the United States, namely, the University of Arizona, the University of Central Florida, and the University of Rochester Laboratory for Laser Energetics. Our desire is to work on programs jointly where the strengths of each organization can assist in escalating knowledge and delivery of systems to the government sponsors and to train the next generation of scientists and engineers to work in the directed energy fields.

 

19

 

 

We have continued to execute our business development plans, further our research and development program and submit filings for intellectual property and proposals for grants and contracts. During the past several years, we continued to submit proposals and have been engaged in meetings on a continuous basis with various agencies and departments both remotely and in person in Washington, DC and at various other government facilities. Having received a significant research grant and several contracts during the past two fiscal years, we believe the interest in our technology and applications remains high, and we continue to submit proposals for all appropriate opportunities and share our vision of the disruptive capabilities of USP optical sources for both near- and far-term threats and dual-use commercial applications.

 

Through our analysis of the market, and in discussions with potential customers, we remain convinced that customers are becoming more receptive and interested in directed energy technologies. According to the US Department of Defense fiscal budgets from 2017 through 2023, its directed energy spending grew from approximately $500 million in 2017 to over $1.695 billion in 2023, an increase of nearly 240%. Market analysis and projections have estimated that this directed energy sector is anticipated to reach $17.8billion globally by 2028. We continue to be optimistic about our future and the growing opportunities in directed energy applications, especially since this growth to nearly $1.7 B annually is being accomplished without a recognized Program of Record (POR) for directed energy platforms. We believe that once these technologies are funded in production for a POR or are approved to be integrated on fielded platforms in volumes to effect threat reduction, these DOD budgets for directed energy will grow exponentially larger to support the technology insertion. The Applied Energetics team anticipates a continuation of strong funding for the directed energy community. With our existing patent portfolio, and through further advancements of our technologies, we believe we have the substantial building blocks needed to become a significant and successful developer in the USP marketplace.

 

Our research and development programs depend on our ability to procure the necessary optical and fabricated materials, components, electronics and other supplies. A significant, prolonged increase in inflation could negatively impact on the cost of materials and components, which could be a particular problem with respect to our fixed fee contracts. Within the current geopolitical context, there are ongoing embargos of exports from some global suppliers of various materials that are used in electronics and some diode and laser materials, which can have negative effects on technology supply chains. We continuously monitor potential supply chain issues and supplier liquidity and work with our supply base to ensure adequate sources of materials at reasonable costs. In some instances, we depend upon a single source of supply, but we are developing multiple sources, both internal to AE and externally where possible to mitigate the risk. In some cases, we must comply with specific procurement requirements, which can limit the suppliers and subcontractors we may utilize.

 

Results of Operations

 

Comparison of Operations for the Three Months Ended March 31, 2024 and 2023:

  

   2024   2023 
Revenue  $134,235   $486,678 
Cost of revenue   274,432    141,272 
General and administrative   (2,316,899)   (2,115,267)
Selling and marketing   (75,559)   (108,890)
Research and development   (80,780)   (59,980)
Interest income (expense)   2,057    (711)
Net loss  $(2,611,379)  $(1,938,020)

 

Revenue

 

Revenue decreased by $352,443 to approximately $134,235 for the three months ended March 31, 2024 from $486,678 for the three months ended March 31, 2023. The decrease in revenue was primarily the result of a contract modification which resulted in a decrease in the contract’s price and an increase in the contract’s term. At the time of modification, the company recorded a catch-up adjustment as a reduction in revenue of approximately $700,000 during the three months ended March 31, 2024.

 

20

 

 

Cost of Revenue

 

Cost of revenue increased by $133,160 to approximately $274,432 for the three months ended March 31, 2024 from $141,272 for the three months ended March 31, 2023. This increase was primarily attributable to an increase in the cost of materials, supplies and direct labor cost incurred in connection with the increased revenues.

 

General and Administrative

 

General and administrative expenses increased by $201,632 to approximately $2,316,899 for the three months ended March 31, 2024, compared to approximately $2,115,267 for the three months ended March 31, 2023, primarily due to an increase in salaries and employee benefits of approximately $650,000 mainly due to non-cash compensation, an increase in travel and meals of approximately $47,000, an increase in software and licenses of approximately $25,000, an increase in depreciation expense of approximately $19,000, partially offset by a decrease of approximately $252,000 in professional and consulting expenses and a change in other expense of $2,000.

 

Selling and Marketing

 

Selling and marketing expenses decreased by $33,331 to approximately $75,559 for the three months ended March 31, 2024, compared to approximately $108,890 for the three months ended March 31, 2023, primarily due to the continuation of business development activities through our Master Services Agreement with Westpark Advisors as well as other consultants in this field.

 

Research and Development

 

Research and development expenses increased by $20,800 to approximately $80,780 for the three months ended March 31, 2024, compared to approximately $59,980 for the three months ended March 31, 2023, primarily due to an increase in labor cost associated with continued development of our USP laser technologies.

 

Net Loss

 

Our operations for the three months ended March 31, 2024, resulted in a net loss of approximately $2,611,379 an increase of approximately $673,359 compared to the approximately $1,938,020 net loss for the three months ended March 31, 2023, primarily due an increase in general and administrative expense and research and development expense partially offset by a decrease in selling and marketing expenses.

 

Liquidity and Capital Resources

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the three months ended March 31, 2024, the company incurred a net loss of approximately $2,611,000, had negative cash flows from operations of approximately $1,542,000 and may incur additional future losses due to the possible reduction in government contract activity and the expenses discussed under Results of Operations. In their report accompanying our financial statements for the year ended December 31, 2023, our independent auditors stated that our financial statements were prepared assuming that we would continue as a going concern and that they have substantial doubt as to our ability to do so for one year from the date the financial statements are issued based on our recurring losses from operations and need to raise additional capital. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

At March 31, 2024, the company had total current assets of $1,667,661 and total current liabilities of $2,154,058 resulting in working capital of ($486,396). At March 31, 2024, we had $1,007,840 of cash and cash equivalents, a decrease of $311,686 from $1,319,526 at December 31, 2023.

 

During the first three months of 2024, the net cash outflow from operating activities was $1,542,327. This amount was comprised primarily of our net loss of $2,611,379, offset by non-cash stock-based compensation expense of $955,730, depreciation and amortization of $52,439, amortization of ROU assets of $47,124 and amortization of prepaid assets of $51,855, and cash used from changes in assets and liabilities of $38,096 from the increase in accounts receivable of $251,095 and accrued expenses and compensation of $36,607 off set by the net decrease in prepaids and deposits of $57,339 operating lease liabilities of $35,529, deferred revenue of $169,582 and a decrease in accounts payable of $63,348.

  

21

 

 

During the first three months of 2024, the net cash inflow from financing activities was $1,230,641. This amount consisted of $1,221,600 in proceeds from stock subscriptions and $16,560 from the exercise of options and warrants, which were offset by $7,519 of tax withholdings related to the share settlement of RSUs.

 

Based on the company’s current business plan, we believe our cash balance as of the date of this report, along with revenue from our government contracts, will be sufficient to meet the company’s anticipated cash requirements for the near term. However, we cannot be certain that the current business plan will be achievable.

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital, as needed, and cannot be certain that these efforts will be successful. Management’s business development efforts may not result in profitable operations. To fund its research and development and marketing efforts, the company’s management continues to explore possible financing opportunities through discussions with investment bankers and private investors. The company may not be successful in its effort to secure additional financing on terms it considers favorable. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.

 

On May 10, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600. All of the purchasers are accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933.

 

ITEM 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024. Based on that evaluation, our Principal Executive Officer has concluded that our disclosure controls and procedures as of March 31, 2024, are not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

 

Changes in Internal Controls Over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

22

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

  

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr.Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received 1,242,710 shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties have completed discovery, and the court has approved a summary judgment briefing schedule proposed by the parties. No trial date has been set.

 

On July 26, 2023, the company filed a complaint in the Superior Court of the State of Delaware against Gusrae Kaplan Nusbaum PLLC and Ryan Whalen, for malicious prosecution of a federal securities fraud lawsuit which was filed by these defendants against the company and certain of its directors, attorneys and their law firms and an outside consultant, in July 2019 in the United States District Court for the Southern District of New York. The complaint filed by the company alleges that the claims by these defendants against it were frivolous and prosecuted for the improper purpose of hindering the company’s prosecution of a then pending case against George Farley, the company’s former CEO, which was later settled. The complaint further alleges that the defendants prosecuted their claim with malice causing the company damages valued in excess of $40 million. On September 11, 2023, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On October 25, 2023, the company filed an opposition to the motion. The court heard oral argument on the motion on January 19, 2024, and took the motion under submission. On April 16, 2024, the court granted the motion on the grounds of lack of personal jurisdiction over the defendants. The company filed a Notice of Appeal with the Supreme Court of the State of Delaware on May 2, 2024.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

The company may, from time to time, be involved in legal proceedings arising from the normal course of business.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The company has reported all information pertaining to issuances of equity securities sold during the period covered by this Quarterly Report on Form 10-Q in previously filed report on Forms 10-K, 10-Q and 8-K.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Trading Arrangements

 

The Rule 10b5-1 Plan previously established by Stephen McCahon, our Chief Science Officer, expired in accordance with its own terms as of March 14, 2024. No trades were executed under this plan.

 

ITEM 6. EXHIBITS

 

EXHIBIT
NUMBER
  DESCRIPTION
23   Consent of RBSM LLP *
31.1   Certification of Chief Executive Officer Pursuant to Exchange Act Rule 13a-14(a).
31.2   Certification of Chief Financial Officer Pursuant to Exchange Act Rule 13a-14(a).
32.1   Principal Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Principal Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF  

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Incorporated by reference to Exhibit 23.1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

 

23

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  

  APPLIED ENERGETICS, INC.
   
  By: /s/ Gregory J. Quarles
    Gregory J. Quarles,
President and
Chief Executive Officer
   
  By: /s/ Christopher Donaghey
    Christopher Donaghey,
Chief Financial
Officer and Chief Operating Officer
   
Date: May 13, 2024  

 

 

24

 

NONE 0.01 0.01 210976434 211323085 false --12-31 Q1 0000879911 0000879911 2024-01-01 2024-03-31 0000879911 2024-05-13 0000879911 2024-03-31 0000879911 2023-12-31 0000879911 us-gaap:RelatedPartyMember 2024-03-31 0000879911 us-gaap:RelatedPartyMember 2023-12-31 0000879911 us-gaap:SeriesAPreferredStockMember 2024-03-31 0000879911 us-gaap:SeriesAPreferredStockMember 2023-12-31 0000879911 2023-01-01 2023-03-31 0000879911 us-gaap:PreferredStockMember 2023-12-31 0000879911 us-gaap:CommonStockMember 2023-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000879911 us-gaap:RetainedEarningsMember 2023-12-31 0000879911 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000879911 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000879911 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000879911 us-gaap:PreferredStockMember 2024-03-31 0000879911 us-gaap:CommonStockMember 2024-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000879911 us-gaap:RetainedEarningsMember 2024-03-31 0000879911 us-gaap:PreferredStockMember 2022-12-31 0000879911 us-gaap:CommonStockMember 2022-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000879911 us-gaap:RetainedEarningsMember 2022-12-31 0000879911 2022-12-31 0000879911 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000879911 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000879911 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000879911 us-gaap:PreferredStockMember 2023-03-31 0000879911 us-gaap:CommonStockMember 2023-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000879911 us-gaap:RetainedEarningsMember 2023-03-31 0000879911 2023-03-31 0000879911 us-gaap:CashAndCashEquivalentsMember 2024-03-31 0000879911 aerg:OakwoodDOInsuranceMember 2024-03-12 2024-03-12 0000879911 aerg:OakwoodDOInsuranceMember 2024-03-31 0000879911 aerg:OakwoodDOInsuranceMember 2024-04-12 2024-04-12 0000879911 2023-01-01 2023-12-31 0000879911 srt:ChiefExecutiveOfficerMember 2018-07-31 2018-07-31 0000879911 aerg:OptionsMember 2023-03-31 0000879911 aerg:OptionsMember 2023-01-01 2023-03-31 0000879911 aerg:OptionsOneMember 2023-03-31 0000879911 aerg:OptionsOneMember 2023-01-01 2023-03-31 0000879911 aerg:OptionsTwoMember 2024-01-01 2024-03-31 0000879911 aerg:OptionsThreeMember 2024-01-01 2024-03-31 0000879911 aerg:OptionsFourMember 2024-01-01 2024-03-31 0000879911 aerg:OptionsFiveMember 2024-01-01 2024-03-31 0000879911 aerg:OptionsSixMember 2024-01-01 2024-03-31 0000879911 aerg:AuthorizedCapitalStockMember 2024-01-01 2024-03-31 0000879911 aerg:AuthorizedCapitalStockMember 2024-01-29 0000879911 2024-01-29 0000879911 us-gaap:ConvertiblePreferredStockMember 2024-01-29 0000879911 us-gaap:ConvertiblePreferredStockMember 2023-12-31 0000879911 us-gaap:ConvertiblePreferredStockMember 2022-12-31 0000879911 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0000879911 srt:MinimumMember 2024-01-01 2024-03-31 0000879911 srt:MaximumMember 2024-01-01 2024-03-31 0000879911 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0000879911 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0000879911 us-gaap:SeriesAPreferredStockMember 2010-10-31 2010-10-31 0000879911 us-gaap:SeriesAPreferredStockMember 2010-11-01 2010-11-01 0000879911 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000879911 aerg:OfficersAndEmployeesMember 2024-01-01 2024-03-31 0000879911 aerg:ExecutiveEmploymentAgreementMember 2023-01-01 2023-12-31 0000879911 us-gaap:StockOptionMember 2023-12-31 0000879911 us-gaap:StockOptionMember 2023-12-31 2023-12-31 0000879911 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0000879911 us-gaap:StockOptionMember 2024-03-31 0000879911 srt:MinimumMember aerg:FairValueOfOptionMember 2023-01-01 2023-03-31 0000879911 srt:MaximumMember aerg:FairValueOfOptionMember 2023-01-01 2023-03-31 0000879911 aerg:FairValueOfOptionMember 2023-01-01 2023-03-31 0000879911 us-gaap:RestrictedStockMember 2023-12-31 0000879911 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000879911 us-gaap:RestrictedStockMember 2024-03-31 0000879911 us-gaap:WarrantMember 2023-12-31 0000879911 us-gaap:WarrantMember 2023-12-31 2023-12-31 0000879911 us-gaap:WarrantMember 2024-01-01 2024-03-31 0000879911 us-gaap:WarrantMember 2024-03-31 0000879911 srt:MinimumMember aerg:ZeroPointZeroFiveZeroPointZeroSevenMember 2024-01-01 2024-03-31 0000879911 srt:MaximumMember aerg:ZeroPointZeroFiveZeroPointZeroSevenMember 2024-01-01 2024-03-31 0000879911 aerg:ZeroPointZeroFiveZeroPointZeroSevenMember 2024-01-01 2024-03-31 0000879911 aerg:ZeroPointZeroFiveZeroPointZeroSevenMember 2024-03-31 0000879911 aerg:OneCustomerMember 2024-01-01 2024-03-31 0000879911 aerg:OneCustomerMember 2024-03-31 0000879911 aerg:OneCustomerMember 2023-03-31 0000879911 aerg:SquareFoodLaboratoryMember 2021-03-31 0000879911 aerg:SquareFoodLaboratoryMember 2023-06-07 0000879911 2023-06-07 0000879911 aerg:GKNAndWhalenMember 2024-03-31 0000879911 2023-07-26 2023-07-26 0000879911 2023-01-31 2023-01-31 0000879911 us-gaap:CommonStockMember 2024-03-31 0000879911 us-gaap:SubsequentEventMember 2024-05-10 0000879911 us-gaap:SubsequentEventMember 2024-05-10 2024-05-10 0000879911 aerg:AdamczykFamily2021LLCMember 2024-01-01 2024-03-31 0000879911 aerg:StephenMcCahonMember 2024-01-01 2024-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqft utr:sqm

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE

PURSUANT TO RULE 15d-14

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gregory J Quarles, the President and Chief Executive Officer of Applied Energetics, Inc., certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Applied Energetics Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Gregory J. Quarles  
Gregory J. Quarles  
President and Chief Executive Officer  

 

Date: May 13, 2024

 

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL

ACCOUNTING OFFICER

PURSUANT TO RULE 15d-14

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Christopher Donaghey, the Chief Financial Officer of Applied Energetics, Inc., certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Applied Energetics Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Christopher Donaghey  
Christopher Donaghey  
Chief Financial Officer  

 

Date: May 13, 2024

 

 

Exhibit 32.1

 

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing by Applied Energetics, Inc. (the “company”) of its Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (the “Report”) I, Gregory J Quarles, President and Chief Executive Officer of the company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

(i)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the company.

 

This certificate is being made for the exclusive purpose of compliance by the chief executive officer of Applied Energetics, Inc. with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 and may not be used for any other purposes. A signed original of this written statement required by Section 906 has been provided to Applied Energetics, Inc. and will be retained by Applied Energetics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

/s/ Gregory J. Quarles  
Gregory J. Quarles  
President and Chief Executive Officer  

 

Date: May 13, 2024

 

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL

ACCOUNTING OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing by Applied Energetics, Inc. (the “company”) of its Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (the “Report”) I, Christopher Donaghey, Chief Financial Officer of the company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

(i)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the company.

 

This certificate is being made for the exclusive purpose of compliance by the chief executive officer of Applied Energetics, Inc. with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 and may not be used for any other purposes. A signed original of this written statement required by Section 906 has been provided to Applied Energetics, Inc. and will be retained by Applied Energetics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

/s/ Christopher Donaghey  
Christopher Donaghey  
Chief Financial Officer  

 

Date: May 13, 2024

 

 

v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 13, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name APPLIED ENERGETICS, INC.  
Entity Central Index Key 0000879911  
Entity File Number 001-14015  
Entity Tax Identification Number 77-0262908  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 9070 S. Rita Road  
Entity Address, Address Line Two Suite 1500  
Entity Address, City or Town Tucson  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85747  
Entity Phone Fax Numbers [Line Items]    
City Area Code (520)  
Local Phone Number 628-7415  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol AERG  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   213,303,285
v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,007,840 $ 1,319,526
Accounts receivable 316,697 567,792
Other assets 343,124 148,338
Total current assets 1,667,661 2,035,656
Long-term assets    
Property and equipment - net 382,124 434,563
Right of use asset - operating 1,007,612 1,054,736
Security deposit 17,004 17,004
Total long-term assets 1,406,741 1,506,303
Total assets 3,074,402 3,541,959
Current liabilities    
Accounts payable 249,610 312,958
Subscription payable 1,221,600  
Notes payable 189,302
Operating lease liability - current 179,023 166,927
Deferred revenue 139,326 308,908
Accrued expenses 77,117 40,510
Accrued dividends 48,079 48,079
Total current liabilities 2,154,058 927,382
Long-term liabilities    
Operating lease liability - non-current 946,866 994,491
Total long-term liabilities 946,866 994,491
Total liabilities 3,100,924 1,921,873
Stockholders’ (Deficit) Equity    
Common stock, $.001 par value, 500,000,000 shares authorized; 211,370,639 and 211,236,688 shares issued and outstanding at March 31, 2024 and at December 31, 2023, respectively 211,371 211,237
Additional paid-in capital 113,187,766 112,223,129
Accumulated deficit (113,425,673) (110,814,294)
Total stockholders’ (deficit) equity (26,522) 1,620,086
Total Liabilities and Stockholders’ (Deficit) Equity 3,074,402 3,541,959
Related parties    
Current liabilities    
Due to related parties 50,000 50,000
Series A convertible preferred stock    
Stockholders’ (Deficit) Equity    
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at March 31, 2024 and December 31, 2023 (Liquidation preference $340,050 and $340,050, respectively) $ 14 $ 14
v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 211,370,639 211,236,688
Common stock, shares outstanding 211,370,639 211,236,688
Series A convertible preferred stock    
Series A convertible preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Series A convertible preferred stock, shares authorized 2,000,000 2,000,000
Series A convertible preferred stock, shares issued 13,602 13,602
Series A convertible preferred stock, shares outstanding 13,602 13,602
Series A convertible preferred stock, liquidation preference (in Dollars) $ 340,050 $ 340,050
v3.24.1.1.u2
Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 134,235 $ 486,678
Cost of revenue 274,432 141,272
Gross profit (140,197) 345,406
Operating expenses    
General and administrative 2,316,899 2,115,267
Selling and marketing 75,559 108,890
Research and development 80,780 59,980
Total operating expenses 2,473,239 2,284,137
Operating loss (2,613,436) (1,938,731)
Other income/(expense)    
Other income 2,057 711
Total other income/(expense) 2,057 711
Loss before provision for income taxes (2,611,379) (1,938,020)
Provision for income taxes
Net loss (2,611,379) (1,938,020)
Preferred stock dividends (8,501) (8,501)
Net loss attributable to common stockholders $ (2,619,880) $ (1,946,521)
Net loss attributable to common stockholders per common share - basic (in Dollars per share) $ (0.01) $ (0.01)
Weighted average number of common shares outstanding, basic (in Shares) 211,323,085 210,976,434
v3.24.1.1.u2
Condensed Consolidated Statements Of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net loss attributable to common stockholders per common share - diluted $ (0.01) $ (0.01)
Weighted average number of common shares outstanding, diluted 211,323,085 210,976,434
v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 14 $ 210,849 $ 108,830,982 $ (103,463,859) $ 5,577,986
Balance (in Shares) at Dec. 31, 2022 13,602 210,848,671      
Stock-based compensation 758,187 758,187
RSU restricted stock $ 10 21,075 21,085
RSU restricted stock (in Shares)   9,584      
Common stock issued on exercise of options $ 175 16,575 16,750
Common stock issued on exercise of options (in Shares)   175,000      
Net loss (1,938,020) (1,938,020)
Balance at Mar. 31, 2023 $ 14 $ 211,034 109,626,819 (105,401,879) 4,435,988
Balance (in Shares) at Mar. 31, 2023 13,602 211,033,255      
Balance at Dec. 31, 2023 $ 14 $ 211,237 112,223,129 (110,814,294) 1,620,086
Balance (in Shares) at Dec. 31, 2023 13,602 211,236,688      
Stock-based compensation 955,730 955,730
Common stock issued on exercise of options $ 60 12,540 $ 12,600
Common stock issued on exercise of options (in Shares)   60,000     16,500
Common stock issued on exercise of warrants $ 66 3,894 $ 3,960
Common stock issued on exercise of warrants (in Shares)   66,000      
Common stock issued for settlement of restricted stock units $ 12 (12)
Common stock issued for settlement of restricted stock units (in Shares)   11,666      
Common stock withheld to cover income tax withholding obligations $ (4) (7,515) (7,519)
Common stock withheld to cover income tax withholding obligations (in Shares)   (3,715)      
Net loss (2,611,379) (2,611,379)
Balance at Mar. 31, 2024 $ 14 $ 211,371 $ 113,187,766 $ (113,425,673) $ (26,522)
Balance (in Shares) at Mar. 31, 2024 13,602 211,370,639      
v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows From Operating Activities    
Net loss $ (2,611,379) $ (1,938,020)
Adjustments to reconcile net loss to net cash used in operating activities:    
Noncash stock based compensation expense 955,730 779,272
Amortization of ROU assets 47,124 29,012
Depreciation and amortization 52,439 24,926
Amortization of prepaid assets 51,855 55,390
Changes in assets and liabilities:    
Accounts receivable 251,095 28,697
Prepaid and deposits (57,339) (216,879)
ROU liabilities (35,529) (22,632)
Accounts payable (63,348) 93,632
Deferred revenue (169,582)
Accrued expenses and compensation 36,607 14,027
Net cash used in operating activities (1,542,327) (1,152,575)
Cash Flows From Investing Activities    
Purchase of equipment (32,096)
Net cash used in investing activities (32,096)
Cash Flows From Financing Activities    
Repayment on note payable (300,000)
Proceeds from note payable 155,541
Proceeds from stock subscription payable 1,221,600
Proceeds from the exercise of stock option and warrants 16,560 16,750
Tax withholdings related to net share settlement of RSU’s (7,519)
Net cash provided by financing activities 1,230,641 (127,709)
Net change in cash and cash equivalents (311,686) (1,312,380)
Cash and cash equivalents, beginning of year 1,319,526 5,640,308
Cash and cash equivalents, at end of period 1,007,840 4,327,928
Supplemental disclosure of cash flow information    
Cash paid for interest
Cash paid for taxes
Non-cash investing and financing activities    
Insurance financing for prepaid insurance $ 189,302 $ 155,541
v3.24.1.1.u2
Organization of Business, Going Concern and Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Abstract]  
ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The unaudited condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2023, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

For the three months ended March 31, 2024, the company incurred a net loss of $2,611,379, had negative cash flows from operations of $1,542,327 and may incur additional future losses due to limited contract activity. At March 31, 2024, the company had total current assets of $1,667,661 and total current liabilities of $2,154,058, resulting in working capital deficit of $486,397. At March 31, 2024, the company had cash of $1,007,840.

 

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from government contracts, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

Trade conditions, such as exacerbated supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine, war in the Middle East, and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital, which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. The company may be unsuccessful in its effort to secure additional equity financing. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include revenue recognition, carrying amounts of long-lived assets, valuation assumptions for share-based payments, evaluation of debt modification accounting, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities.

 

Net Loss Attributable to Common Stockholders

 

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of shares underlying warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 31,347,519 and 28,757,351 for the three months ended March 31, 2024 and 2023, respectively.

 

Significant Concentrations and Risks

 

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of March 31, 2024, $505,111 was uninsured.

v3.24.1.1.u2
New Accounting Standards
3 Months Ended
Mar. 31, 2024
New Accounting Standards [Abstract]  
NEW ACCOUNTING STANDARDS

NOTE 2 – NEW ACCOUNTING STANDARDS

 

The company has reviewed all issued accounting pronouncements. The company does not expect the adoption of any pronouncements to have an impact on its results of operations or financial position.

v3.24.1.1.u2
Notes Payable
3 Months Ended
Mar. 31, 2024
Notes Payable [Abstract]  
NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

 

Premium Financing

 

On March 12, 2024, the company entered into an agreement with Oakwood D&O Insurance to provide financing in the amount of $189,302 for the insurance premium associated with two D&O policies. Both policies commenced March 12, 2024, and provided coverage for the next 15 months, expiring June 11, 2025. The loan bears interest at a fixed rate of 9.50% per annum and required the company to prepay $41,057 and appears on the balance sheet as a current asset. On April 12, 2024, the company commenced monthly principal and interest payments of $15,775 which was the first payment of twelve remaining months due of $189,302, the last payment of which is scheduled to be made on March 12, 2025. As of March 31, 2024, the outstanding balance on the note was $189,302 and was recorded as notes payable, a currently liability, in the company’s unaudited condensed consolidated balance sheet.

 

Notes Payable Reconciliation

 

The following reconciles notes payable as of March 31, 2024, and December 31, 2023:

 

   March 31,
2024
   December 31,
2023
 
Beginning balance  $-   $400,000 
Notes payable   189,302    155,541 
Payments on notes payable   -    (555,541)
Total   189,302    - 
Less-Notes payable – current   189,302    - 
Notes payable – non-current  $-   $- 

 

Future principal payments for the company’s Notes as of March 31, 2024, are as follows:

 

2024, nine months ended  $141,977 
2025   47,325 
Thereafter   
-
 
Total  $189,302 

 

The company’s note payable balance of $189,302 is due within the next twelve months, in accordance with the terms of note payable.

v3.24.1.1.u2
Due to Related Parties
3 Months Ended
Mar. 31, 2024
Due to Related Parties [Abstract]  
DUE TO RELATED PARTIES

NOTE 4 – DUE TO RELATED PARTIES

 

It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.

v3.24.1.1.u2
Stockholders’ Equity
3 Months Ended
Mar. 31, 2024
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

 

Authorized Capital Stock

 

During the three months ended March 31, 2023, the company issued 100,000 shares of common stock upon the exercise of 100,000 options at an exercise price of $0.07 a share. As a result, the company received $7,000 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2023, the company issued 75,000 shares of common stock upon the exercise of 75,000 options at an exercise price of $0.13 a share. As a result, the company received $9,750 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2023, the company issued the remaining 9,584 shares of common stock pursuant to a restricted stock agreement dated May 2021.

 

During the three months ended March 31, 2024, the company issued 30,000 shares of common stock upon the exercise of 30,000 options at an exercise price of $0.07 a share. As a result, the company received $2,100 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2024, the company issued 30,000 shares of common stock upon the exercise of 30,000 options at an exercise price of $0.35 a share. As a result, the company received $10,500 in cash proceeds as part of the transaction.

 

During the three months ended March 31, 2024, the company issued 66,000 shares of common stock upon exercise of warrants at an exercise price of $ 0.06 per share. The company received $3,960 in proceeds from the exercise of such options.

 

During the three months ended March 31, 2024, restricted stock units covering 11,666 shares of the company’s common stock vested. The company issued 11,666 and withheld 3,715 shares of common stock from the holder pursuant to their restricted stock unit agreements to cover its tax withholding obligation of $7,519.  

 

Commencing January 29, 2024, the company is conducting an offering of up to one million shares of its common stock, par value, $0.001 per share. To date, the company has received subscriptions in the amount of $1,221,600 but has not yet conducted a closing of the offering.

 

Preferred Stock

 

As of March 31, 2024, and December 31, 2023, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of March 31, 2024, including previously accrued dividends of $48,079 included in our balance sheet total approximately $371,127. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year.

 

Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing.

 

Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.

 

If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.

 

If the Corporation pays all or a portion of the Purchase Price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the Corporation may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the Corporation has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the Corporation and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the Corporation.

 

Share-Based Payments

 

Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan.

 

We have, from time to time, also granted non-plan options and restricted stock units to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $955,730 and $779,272 for the three months ended March 31, 2024, and 2023, respectively, which was charged to general and administrative expense.

 

The $955,730 stock-based compensation for the three months ended March 31, 2024, was comprised of $493,740 option expense, $461,990 expense from the vesting of the restricted stock.

 

The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance.

 

As of March 31, 2024, the company has $8,454,252 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years.

 

The following table summarizes the activity of our stock options for the three months ended March 31, 2024:

 

    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Contractual
Term
Outstanding
    Intrinsic
Value
 
Outstanding at December 31, 2023     26,195,434     $ 0.64       9.37     $ 226,821,848  
Granted     -       -       -       -  
Exercised     (60,000 )     (0.21 )     4.84       (290,219 )
Forfeited or expired     -       -       -       -  
Outstanding at March 31, 2024     26,135,434       0.64       5.76       227,112,067  
Outstanding and exercisable at March 31, 2024     21,379,320       0.28       5.03       107,630,786  

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table:

  

   Three Months
Ended
March 31,
   2023
Assumptions:   
Risk-free interest rate  1.26 – 1.30%
Expected dividend yield  0%
Expected volatility  112.6 –111.62%
Expected life (in years)  6

 

The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the three months ended March 31, 2024, was as follows:

 

   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
Nonvested at December 31, 2023   3,480,454    2.15 
Granted – restricted stock units and awards   -    - 
Granted – performance-based stock units   -    - 
Canceled   -    - 
Vested   (11,666)    6.75 
Nonvested at March 31, 2024   3,468,788   $2.15 

As of March 31, 2024, and December 31, 2023, there was $4,719,593 and $5,181,584, respectively in unrecognized stock- based compensation related to unvested restricted stock agreements, net of estimated forfeitures.

 

As of March 31, 2024 and December 31, 2023, the company recorded $0 and $0, respectively, in unrecognized stock- based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $0 and $0 was amortized for the three months ended March 31, 2024 and 2023, respectively. Warrant stock activity for the three months ended March 31, 2024, was as follows:

 

  

Warrant Activity

 
       Weighted
Average
Exercise
   Weighted
Average
remaining
Contractual
Term
 
   Shares   Price   (years) 
Outstanding at December 31, 2023   1,750,000   $0.0600    5.53 
Granted   -    -    - 
Exercised   (66,000)   0.0600    5.28 
Forfeited   -    -    - 
Outstanding and exercisable at March 31, 2024   1,684,000   $0.0600    5.28 

 

    Warrants Outstanding     Warrants Exercisable  
          Weighted
Avg.
Remaining
      Weighted             Weighted  
     Shares     Contractual
Life in
    Avg.
Exercise
    Shares     Avg.
Exercise
 
Range of Exercise Prices   Outstanding     Years     Price     Exercisable     Price  
$0.05 – $0.07     1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  
      1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  
v3.24.1.1.u2
Revenue Recognition
3 Months Ended
Mar. 31, 2024
Revenue Recognition [Abstract]  
REVENUE RECOGNITION

NOTE 6 – REVENUE RECOGNITION

 

The company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the company over the contract term at a fixed contract price.

 

During the three months ended March 31, 2024, the Company modified its contract with a customer for changes in the contract specifications and requirements. The modification was for services that are not distinct from the existing contract due to the significant integration of services performed. The modification was accounted for as if it was part of the existing contract and a cumulative catch-up adjustment was recorded for the three months ended March 31, 2024.

 

Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in the contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and, therefore, are accounted for as part of the existing contract.

 

The following table summarizes the company’s accounts receivable, net,

 

    March 31,
2024
    December 31,
2023
 
Accounts receivable   $ 316,697     $ 153,029  
Unbilled receivable     -       414,763  
Total   $ 316,697     $ 567,792  

 

Concentrations

 

During the three months ended March 31, 2024, the company earned revenue from three contracts with three separate customers. The three customers accounted for a total of $134,235 in revenue or 100% of revenue recognized during the period. As of March 31, 2024, the company has $316,697 or 100% of accounts receivable recorded as current assets on the balance sheet related to these customers. During the three months ended March 31, 2023, the company earned revenue from one contract with one customer. The customer accounted for $486,678 or 100% of revenue recognized during the period. As of March 31, 2023, the company had $324,452 of accounts receivable recorded as current assets on the balance sheet related to this customer.

v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7– COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one and escalated to $ 9.2009 per rentable square foot in year two. It is to further escalate to $11.4806 per rentable square foot in year three, $13.1740 per rentable square foot in year four and $14.9306 per rentable square foot in year five, in addition to certain operating expenses and taxes.

 

On June 7, 2023, the company entered into an amendment to extend the term of the original lease from April 26, 2026 to July31, 2028. Included in the lease amendment is extension space commencing on August 1, 2023. As of August 1, 2023 the Company has secured additional square footage in the amount of 9,805 rentable square feet (8,375 usable square feet). The initial base rent for expansion space was $9.10 per rentable square foot for year one, and escalated to $10.20 in year two, $11.30 in year three, $12.40 in year four and $13.50 in year five, plus certain operating expenses and taxes.

 

The company incurred lease expense for its operating leases of $72,272 which was included in general and administrative expenses in the statements of operation for the period ended March 31, 2024. During the three months ended March 31, 2024, the company made cash lease payments in the amount of $60,677.

 

At March 31, 2024, we had approximately $130,206 in future minimum lease payments due for the nine months ended. The below table presents the future minimum lease payments due reconciled to lease liabilities.

 

    Operating
Lease
 
For the three months ended March 31, 2024      
2024, nine months ended   $ 130,206  
2025     296,284  
2026     324,429  
2027     343,544  
2028     205,111  
Thereafter     -  
Total undiscounted lease payments     1,370,987  
Present value discount, less interest     245,099  
Lease Liability   $ 1,125,889  

 

Guarantees

 

The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of March 31, 2024 and 2023.

 

Litigation

 

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr.Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received 1,242,710 shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties have completed discovery, and the court has approved a summary judgment briefing schedule proposed by the parties. No trial date has been set.

 

On July 26, 2023, the company filed a complaint in the Superior Court of the State of Delaware against Gusrae Kaplan Nusbaum PLLC and Ryan Whalen, for malicious prosecution of a federal securities fraud lawsuit which was filed by these defendants against the company and certain of its directors, attorneys and their law firms and an outside consultant, in July 2019 in the United States District Court for the Southern District of New York. The complaint filed by the company alleges that the claims by these defendants against it were frivolous and prosecuted for the improper purpose of hindering the company’s prosecution of a then pending case against George Farley, the company’s former CEO, which was later settled. The complaint further alleges that the defendants prosecuted their claim with malice causing the company damages valued in excess of $40 million. On September 11, 2023, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On October 25, 2023, the company filed an opposition to the motion. The court heard oral argument on the motion on January 19, 2024, and took the motion under submission. On April 16, 2024, the court granted the motion on the grounds of lack of personal jurisdiction over the defendants. The company filed a Notice of Appeal with the Supreme Court of the State of Delaware on May 2, 2024.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

The company may, from time to time, be involved in legal proceedings arising from the normal course of business.

 

Related Party

 

In January 2023, the company made a $25,000 tax-deductible donation to Silicon Valley Defense Group (SVDG), a 501(c)(3) organization of which Christopher Donaghey, our Chief Financial and Operating Officer, is a founder and member of the Board of Directors. As its objective, SVDG “seeks to align and connect the people, capital, and ideas that will ensure allied democracies retain a durable techno-security advantage.”

v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS 

 

The company’s management has evaluated subsequent events occurring after March 31, 2024, the date of our most recent balance sheet, through the date our financial statements were issued.

 

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.07 per share. The company received $700 in cash proceeds, minus required withholding, from the exercise of such options.

 

Subsequent to the year period ended March 31, 2024, the company issued 10,000 shares of common stock upon the exercise of options at an exercise price of $0.35 per share. The company received $3,500 in cash proceeds, minus required withholding, from the exercise of such options.

 

Subsequent to the year period ended March 31, 2024, the company issued 16,500 shares of common stock upon exercise of warrants at an exercise price of $0.06 per share. The company received $990 in proceeds from the exercise of such options.

 

On May 10, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600. All of the purchasers are accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933.

v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (2,611,379) $ (1,938,020)
v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Adamczyk Family 2021 LLC [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

The Rule 10b5-1 Plan previously established by Stephen McCahon, our Chief Science Officer, expired in accordance with its own terms as of March 14, 2024. No trades were executed under this plan.

Name Stephen McCahon
Title Chief Science Officer
Stephen McCahon [Member]  
Trading Arrangements, by Individual  
Expiration Date March 14, 2024
v3.24.1.1.u2
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2023, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

Going Concern

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

For the three months ended March 31, 2024, the company incurred a net loss of $2,611,379, had negative cash flows from operations of $1,542,327 and may incur additional future losses due to limited contract activity. At March 31, 2024, the company had total current assets of $1,667,661 and total current liabilities of $2,154,058, resulting in working capital deficit of $486,397. At March 31, 2024, the company had cash of $1,007,840.

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from government contracts, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

Trade conditions, such as exacerbated supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine, war in the Middle East, and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital, which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. The company may be unsuccessful in its effort to secure additional equity financing. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

Use of Estimates

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include revenue recognition, carrying amounts of long-lived assets, valuation assumptions for share-based payments, evaluation of debt modification accounting, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities.

Net Loss Attributable to Common Stockholders

Net Loss Attributable to Common Stockholders

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of shares underlying warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 31,347,519 and 28,757,351 for the three months ended March 31, 2024 and 2023, respectively.

 

Significant Concentrations and Risks

Significant Concentrations and Risks

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of March 31, 2024, $505,111 was uninsured.

v3.24.1.1.u2
Notes Payable (Tables)
3 Months Ended
Mar. 31, 2024
Notes Payable [Abstract]  
Schedule of Reconciles Notes Payable The following reconciles notes payable as of March 31, 2024, and December 31, 2023:
   March 31,
2024
   December 31,
2023
 
Beginning balance  $-   $400,000 
Notes payable   189,302    155,541 
Payments on notes payable   -    (555,541)
Total   189,302    - 
Less-Notes payable – current   189,302    - 
Notes payable – non-current  $-   $- 

 

Schedule of Future Principal Payments Future principal payments for the company’s Notes as of March 31, 2024, are as follows:
2024, nine months ended  $141,977 
2025   47,325 
Thereafter   
-
 
Total  $189,302 
v3.24.1.1.u2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders’ Equity [Abstract]  
Schedule of Stock Option Activity The following table summarizes the activity of our stock options for the three months ended March 31, 2024:
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Contractual
Term
Outstanding
    Intrinsic
Value
 
Outstanding at December 31, 2023     26,195,434     $ 0.64       9.37     $ 226,821,848  
Granted     -       -       -       -  
Exercised     (60,000 )     (0.21 )     4.84       (290,219 )
Forfeited or expired     -       -       -       -  
Outstanding at March 31, 2024     26,135,434       0.64       5.76       227,112,067  
Outstanding and exercisable at March 31, 2024     21,379,320       0.28       5.03       107,630,786  
Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table:
   Three Months
Ended
March 31,
   2023
Assumptions:   
Risk-free interest rate  1.26 – 1.30%
Expected dividend yield  0%
Expected volatility  112.6 –111.62%
Expected life (in years)  6
Schedule of Fair Value of Restricted Stock and Restricted Stock Units The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the three months ended March 31, 2024, was as follows:
   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
Nonvested at December 31, 2023   3,480,454    2.15 
Granted – restricted stock units and awards   -    - 
Granted – performance-based stock units   -    - 
Canceled   -    - 
Vested   (11,666)    6.75 
Nonvested at March 31, 2024   3,468,788   $2.15 

Schedule of Warrant Stock Activity Warrant stock activity for the three months ended March 31, 2024, was as follows:
  

Warrant Activity

 
       Weighted
Average
Exercise
   Weighted
Average
remaining
Contractual
Term
 
   Shares   Price   (years) 
Outstanding at December 31, 2023   1,750,000   $0.0600    5.53 
Granted   -    -    - 
Exercised   (66,000)   0.0600    5.28 
Forfeited   -    -    - 
Outstanding and exercisable at March 31, 2024   1,684,000   $0.0600    5.28 
Schedule of Range Exercise Prices Warrants Outstanding and Exercisable
    Warrants Outstanding     Warrants Exercisable  
          Weighted
Avg.
Remaining
      Weighted             Weighted  
     Shares     Contractual
Life in
    Avg.
Exercise
    Shares     Avg.
Exercise
 
Range of Exercise Prices   Outstanding     Years     Price     Exercisable     Price  
$0.05 – $0.07     1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  
      1,684,000       5.28     $ 0.0600       1,684,000     $ 0.0600  
v3.24.1.1.u2
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2024
Revenue Recognition [Abstract]  
Schedule of Accounts Receivable, Net The following table summarizes the company’s accounts receivable, net,
    March 31,
2024
    December 31,
2023
 
Accounts receivable   $ 316,697     $ 153,029  
Unbilled receivable     -       414,763  
Total   $ 316,697     $ 567,792  
v3.24.1.1.u2
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
Schedule of Future Minimum Lease Payments At March 31, 2024, we had approximately $130,206 in future minimum lease payments due for the nine months ended. The below table presents the future minimum lease payments due reconciled to lease liabilities.
    Operating
Lease
 
For the three months ended March 31, 2024      
2024, nine months ended   $ 130,206  
2025     296,284  
2026     324,429  
2027     343,544  
2028     205,111  
Thereafter     -  
Total undiscounted lease payments     1,370,987  
Present value discount, less interest     245,099  
Lease Liability   $ 1,125,889  

 

v3.24.1.1.u2
Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Line Items]        
Net loss $ (2,611,379) $ (1,938,020)    
Cash flows from operations (1,542,327) (1,152,575)    
Current assets 1,667,661   $ 2,035,656  
Current liabilities 2,154,058   927,382  
Working capital 486,397      
Cash $ 1,007,840 $ 4,327,928 $ 1,319,526 $ 5,640,308
Earning per share antidilutive (in Shares) 31,347,519 28,757,351    
Cash Equivalents [Member]        
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Line Items]        
Cash balance was uninsured $ 505,111      
v3.24.1.1.u2
Notes Payable (Details) - USD ($)
Apr. 12, 2024
Mar. 12, 2024
Mar. 31, 2024
Dec. 31, 2023
Notes Payable [Line Items]        
Current asset     $ 343,124 $ 148,338
Notes payable     $ 189,302
Oakwood D&O Insurance [Member]        
Notes Payable [Line Items]        
Financing amount   $ 189,302    
Fixed rate     9.50%  
Current asset     $ 41,057  
Principal and interest payments $15,775      
Payment of principle interest $ 189,302      
Notes payable     $ 189,302  
v3.24.1.1.u2
Notes Payable (Details) - Schedule of Reconciles Notes Payable - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Reconciles Notes Payable [Abstract]    
Beginning balance $ 400,000
Notes payable 189,302 155,541
Payments on notes payable (555,541)
Total 189,302
Less-Notes payable – current 189,302
Notes payable – non-current
v3.24.1.1.u2
Notes Payable (Details) - Schedule of Future Principal Payments
Mar. 31, 2024
USD ($)
Schedule of Future Principal Payments [Abstract]  
2024, nine months ended $ 141,977
2025 47,325
Thereafter
Total $ 189,302
v3.24.1.1.u2
Due to Related Parties (Details)
Jul. 31, 2018
USD ($)
CEO [Member]  
Due to Related Parties [Line Items]  
Deposited $ 50,000
v3.24.1.1.u2
Stockholders’ Equity (Details) - USD ($)
3 Months Ended 12 Months Ended
Nov. 01, 2010
Oct. 31, 2010
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jan. 29, 2024
Dec. 31, 2022
Stockholders' Equity [Line Items]              
Common stock shares (in Shares)     211,370,639   211,236,688    
Common stock exercise share (in Shares)     16,500        
Exercise price per share (in Dollars per share)     $ 0.06        
Cash proceeds     $ 700        
Exercise price per share (in Dollars per share)     $ 0.35        
Restricted stock unit agreements (in Shares)       9,584      
Exercise price     $ 990        
Restricted stock     $ 461,990        
Withheld (in Shares)     3,715        
Tax withholding obligation     $ 7,519        
Subscriptions received           $ 1,221,600  
Accrued dividends     48,079        
Balance sheet total     $ 371,127        
Weighted average of the last sales prices     95.00%        
Preferred stock per value (in Dollars per share)     $ 12        
Common stock greater than conversion price (in Dollars per share)     $ 140        
Discount at common stock from fair market value     95.00%        
Shares issuance under the plan     $ 50,000,000        
Stock-based compensation     955,730 $ 779,272 $ 779,272    
Share based compensation expenses     955,730        
Option expense     493,740        
Unrecognized compensation cost     $ 8,454,252        
Common stock issued (in Shares)     0   0    
Deferred compensation equity     $ 5,000,000        
Shares Issued Price Per Share (in Dollars per share)     $ 0.4014        
Amortized cost     $ 0 $ 0      
Minimum [Member]              
Stockholders' Equity [Line Items]              
Dividend rate     1.00%        
Maximum [Member]              
Stockholders' Equity [Line Items]              
Dividend rate     6.50%        
Officers and Employees [Member]              
Stockholders' Equity [Line Items]              
Share based compensation expenses     $ 4,719,593        
Executive Employment Agreement [Member]              
Stockholders' Equity [Line Items]              
Share based compensation expenses         $ 5,181,584    
Options [Member]              
Stockholders' Equity [Line Items]              
Common stock shares (in Shares)       100,000      
Common stock exercise share (in Shares)       100,000      
Exercise price per share (in Dollars per share)       $ 0.07      
Cash proceeds       $ 7,000      
Authorized Capital Stock [Member]              
Stockholders' Equity [Line Items]              
Common stock exercise share (in Shares)     11,666        
Preferred stock shares (in Shares)           1,000,000  
Preferred stock par value (in Dollars per share)           $ 0.001  
Series A Convertible Preferred Stock [Member]              
Stockholders' Equity [Line Items]              
Series A convertible preferred stock, issued (in Shares)         13,602 13,602  
Preferred shares outstanding (in Shares)         13,602   13,602
Series A Preferred Stock [Member]              
Stockholders' Equity [Line Items]              
Preferred stock shares (in Shares)     2,000,000   2,000,000    
Preferred stock par value (in Dollars per share)     $ 0.001   $ 0.001    
Series A convertible preferred stock, issued (in Shares)     13,602   13,602    
Preferred shares outstanding (in Shares)     13,602   13,602    
Liquidation preference per share (in Dollars per share)     $ 25        
Series A preferred stock, dividend rate     6.50%        
Liquidation preference, percentage 100.00% 100.00% 101.00%        
Series A Preferred Stock [Member] | Minimum [Member]              
Stockholders' Equity [Line Items]              
Preferred stock liquidation preference     7.50%        
Series A Preferred Stock [Member] | Maximum [Member]              
Stockholders' Equity [Line Items]              
Preferred stock liquidation preference     10.00%        
Common Stock [Member]              
Stockholders' Equity [Line Items]              
Common stock shares (in Shares)     10,000        
Discount at common stock from fair market value     5.00%        
Options One [Member]              
Stockholders' Equity [Line Items]              
Common stock shares (in Shares)       75,000      
Common stock exercise share (in Shares)       75,000      
Cash proceeds       $ 9,750      
Exercise price per share (in Dollars per share)       $ 0.13      
Options Two [Member]              
Stockholders' Equity [Line Items]              
Common stock exercise share (in Shares)     30,000        
Exercise price per share (in Dollars per share)     $ 30,000        
Cash proceeds     $ 2,100        
Exercise price     $ 0.07        
Options Three [Member]              
Stockholders' Equity [Line Items]              
Common stock exercise share (in Shares)     30,000        
Exercise price per share (in Dollars per share)     $ 30,000        
Exercise price     $ 0.35        
Options Four [Member]              
Stockholders' Equity [Line Items]              
Cash proceeds     $ 10,500        
Options Five [Member]              
Stockholders' Equity [Line Items]              
Common stock exercise share (in Shares)     66,000        
Exercise price per share (in Dollars per share)     $ 0.06        
Options Six [Member]              
Stockholders' Equity [Line Items]              
Exercise price     $ 3,960        
Common Stock [Member]              
Stockholders' Equity [Line Items]              
Common stock exercise share (in Shares)     60,000 175,000      
Restricted stock     $ 11,666        
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Stock Option Activity - Stock Options [Member] - USD ($)
3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Schedule of Stock Option Activity [Line Items]    
Shares, Outstanding 26,195,434 26,135,434
Weighted Average Exercise Price, Outstanding $ 0.64 $ 0.64
Weighted Average Contractual Term Outstanding, Outstanding 9 years 4 months 13 days 5 years 9 months 3 days
Intrinsic Value, Outstanding $ 226,821,848 $ 227,112,067
Shares, Outstanding and exercisable   21,379,320
Weighted Average Exercise Price, Outstanding and exercisable   $ 0.28
Weighted Average Contractual Term, Outstanding and exercisable   5 years 10 days
Intrinsic Value, Outstanding and exercisable   $ 107,630,786
Shares, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Contractual Term Outstanding, Granted  
Intrinsic Value, Granted  
Shares, Exercised   (60,000)
Weighted Average Exercise Price, Exercised   $ (0.21)
Weighted Average Contractual Term Outstanding, Exercised   4 years 10 months 2 days
Intrinsic Value, Exercised   $ (290,219)
Shares, Forfeited or expired  
Weighted Average Exercise Price, Forfeited or expired  
Weighted Average Contractual Term Outstanding, Forfeited or expired  
Intrinsic Value, Forfeited or expired  
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions - Fair Value of Option [Member]
3 Months Ended
Mar. 31, 2023
Assumptions:  
Expected dividend yield 0.00%
Expected life (in years) 6 years
Minimum [Member]  
Assumptions:  
Risk-free interest rate 1.26%
Expected volatility 112.60%
Maximum [Member]  
Assumptions:  
Risk-free interest rate 1.30%
Expected volatility 111.62%
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Fair Value of Restricted Stock and Restricted Stock Units - Restricted Stock [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Schedule of Fair Value of Restricted Stock and Restricted Stock Units [Line Items]  
Shares Outstanding, Balance ending | shares 3,480,454
Weighted Average Exercise Price, Balance ending | $ / shares $ 2.15
Shares, Vested and converted to shares | shares 3,468,788
Weighted Average Fair Value per Share at Grant Date, Vested and converted to shares | $ / shares $ 2.15
Shares, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Shares, Canceled | shares
Weighted Average Exercise Price, Canceled | $ / shares
Shares, Vested and converted to shares | shares (11,666)
Weighted Average Fair Value per Share at Grant Date, Vested and converted to shares | $ / shares $ 6.75
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Warrant Stock Activity - Warrant [Member] - $ / shares
3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Stockholders’ Equity (Details) - Schedule of Warrant Stock Activity [Line Items]    
Shares Granted  
Weighted Average Exercise Price Granted  
Shares Exercised   (66,000)
Weighted Average Exercise Price Exercised   $ 0.06
Weighted Average remaining Contractual Term Exercised   5 years 3 months 10 days
Shares Forfeited  
Weighted Average Exercise Price Forfeited  
Shares, Outstanding 1,750,000 1,684,000
Weighted Average Exercise Price, Outstanding $ 0.06 $ 0.06
Weighted Average Contractual Term Outstanding, Outstanding 5 years 6 months 10 days 5 years 3 months 10 days
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Range Exercise Prices Warrants Outstanding and Exercisable
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding 1,684,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years 5 years 3 months 10 days
Warrants Outstanding, Weighted Avg. Exercise Price (in Dollars per share) | $ / shares $ 0.06
Warrants Exercisable, Shares Exercisable 1,684,000
Warrants Exercisable, Weighted Avg. Exercise Price (in Dollars per share) | $ / shares $ 0.06
$0.05 – $0.07 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding 1,684,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years 5 years 3 months 10 days
Warrants Outstanding, Weighted Avg. Exercise Price (in Dollars per share) | $ / shares $ 0.06
Warrants Exercisable, Shares Exercisable 1,684,000
Warrants Exercisable, Weighted Avg. Exercise Price (in Dollars per share) | $ / shares $ 0.06
Minimum [Member] | $0.05 – $0.07 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding 0.05
Maximum [Member] | $0.05 – $0.07 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding 0.07
v3.24.1.1.u2
Revenue Recognition (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Revenue Recognition [Line Items]      
Earned revenue $ 316,697 $ 486,678  
Earned revenue, percentage 100.00%    
Accounts receivable $ 316,697   $ 567,792
One Customer [Member]      
Revenue Recognition [Line Items]      
Earned revenue $ 134,235    
Earned revenue, percentage 100.00% 100.00%  
Accounts receivable   $ 324,452  
v3.24.1.1.u2
Revenue Recognition (Details) - Schedule of Accounts Receivable, Net - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Schedule of Accounts Receivable, Net [Abstract]    
Accounts receivable $ 316,697 $ 153,029
Unbilled receivable 414,763
Total $ 316,697 $ 567,792
v3.24.1.1.u2
Commitments and Contingencies (Details)
3 Months Ended
Jul. 26, 2023
USD ($)
Jan. 31, 2023
USD ($)
Mar. 31, 2024
USD ($)
shares
Jun. 07, 2023
USD ($)
Mar. 31, 2021
USD ($)
ft²
Commitments and Contingencies [Line Items]          
Lease area | m²       8,375  
Lease expense     $ 72,272    
Cash lease payments amount     60,677    
Future minimum lease payments     $ 130,206    
Common stock shares (in Shares) | shares     10,000    
Excess of damages value $ 40,000,000        
Tax deductible   $ 25,000      
GKN and Whalen [Member]          
Commitments and Contingencies [Line Items]          
Common stock shares (in Shares) | shares     1,242,710    
Square Foot Laboratory/Office Space [Member]          
Commitments and Contingencies [Line Items]          
Lease area       9,805 13,000
Rentable square foot for year one       $ 9.1 $ 6.7626
Rentable square foot for year two       10.2 9.2009
Rentable square foot for year three       11.3 11.4806
Rentable square foot for year four       12.4 13.174
Rentable square foot for year five       $ 13.5 $ 14.9306
v3.24.1.1.u2
Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments
Mar. 31, 2024
USD ($)
Schedule of Future Minimum Lease Payments [Abstract]  
2024, nine months ended $ 130,206
2025 296,284
2026 324,429
2027 343,544
2028 205,111
Thereafter
Total undiscounted lease payments 1,370,987
Present value discount, less interest 245,099
Lease Liability $ 1,125,889
v3.24.1.1.u2
Subsequent Events (Details) - USD ($)
3 Months Ended
May 10, 2024
Mar. 31, 2024
Dec. 31, 2023
Subsequent Events [Line Items]      
Shares issued (in Shares)   10,000  
Exercise price per share   $ 0.07  
Cash proceeds (in Dollars)   $ 700  
Common stock shares (in Shares)   211,370,639 211,236,688
Exercise price per share   $ 0.35  
Cash proceeds (in Dollars)   $ 3,500  
Common stock exercise share (in Shares)   16,500  
Exercise price per share   $ 0.06  
Exercise price (in Dollars)   $ 990  
Common stock, par value   $ 0.001 $ 0.001
Common Stock [Member]      
Subsequent Events [Line Items]      
Common stock shares (in Shares)   10,000  
Subsequent Event [Member]      
Subsequent Events [Line Items]      
Common stock shares (in Shares) 1,896,182    
Common stock, par value $ 0.001    
Price, per share $ 2.2    
Aggregate proceeds (in Dollars) $ 4,171,600    

Applied Energetics (PK) (USOTC:AERGP)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Applied Energetics (PK) Charts.
Applied Energetics (PK) (USOTC:AERGP)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Applied Energetics (PK) Charts.